Navigation Links
Gabapentin inhibits central sensitization during migraine
Date:1/6/2014

Gabapentin is a gamma-aminobutyric acid derivative, and was approved for the treatment of neuropathic pain by the U.S. Food and Drug Administration in 2002. However, little evidence is available on the effects and me-chanisms of action of gabapentin during the migraine attack period. A recent study by Yanbo Zhang and colleague from Xuanwu Hospital, Capital Medical University in China showed that excitatory amino acids and protein kinase C are involved in the formation and maintenance of central sensitization during migraine. Gabapentin can decrease neuronal excitability in spinal trigeminal nuclei and inhibit the formation of central sensitization during migraine by reducing excitatory amino acid content in the cerebrospinal fluid and by inhibiting protein kinase C activation. These findings were published in the Neural Regeneration Research (Vol. 8, No. 32, 2013).


'/>"/>

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
Source:Eurekalert  

Page: 1

Related biology news :

1. How the Parkin enzyme inhibits neuronal cell death
2. Active component from wine-processed Fructus corni inhibits hippocampal neuron apoptosis
3. Gene transduction inhibits post-epileptic hippocampal synaptic reconstruction
4. New agent inhibits HCV replication in mouse models -- No resistance seen
5. Molecule found that inhibits estrogen, key risk factor for endometrial and breast cancers
6. BGI scientists win BioMed Central Open Data Award
7. Richness mapping and prediction of amphibians in Southern and Central China
8. Research uncovers potential preventive for central line infection
9. New virus discovered in patients with central nervous system infections
10. Snap shots of 1 of lifes central processes
11. New evidence shows PubMed Central undermines journal usage
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gabapentin inhibits central sensitization during migraine
(Date:3/27/2017)... CENTRE, N.Y. , March 27, 2017 /PRNewswire-USNewswire/ ... Healthcare Information and Management Systems Society (HIMSS) Analytics ... Outpatient EMR Adoption Model sm . In addition, ... 12% of U.S. hospitals using an electronic medical ... CHS for its high level of EMR usage ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... - Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle ... around 15.1% over the next decade to reach approximately $1,580 million ... estimates and forecasts for all the given segments on global as ...
(Date:3/23/2017)... Research and Markets has announced the addition of the "Global ... 2025" report to their offering. ... The Global Vehicle Anti-Theft System Market is ... next decade to reach approximately $14.21 billion by 2025. ... all the given segments on global as well as regional levels ...
Breaking Biology News(10 mins):
(Date:5/22/2017)... ... May 22, 2017 , ... Baltimore ... of the Maryland Biohealth community in developing and issuing recommendations to grow Maryland's ... BioHealth Innovation Hub by 2023. , The recommendations are contained ...
(Date:5/19/2017)... (PRWEB) , ... May 19, 2017 , ... ... QED Proof-of-Concept Program. Academic researchers with technologies ripe for commercialization, and who ... Jersey and Delaware, are encouraged to submit proposals. QED, now in its tenth ...
(Date:5/18/2017)... ... May 17, 2017 , ... ... psychonneuroendocrine stress expertise, and further enhances its scientific power by providing investigators ... Granger, Ph.D., has agreed to join the scientific advisory board. “We are ...
(Date:5/18/2017)... Mass. (PRWEB) , ... May 17, 2017 , ... ... bias. Women, for example, are more likely to develop Alzheimer’s disease, while men ... that may account for this gender-specific neuronal bias is the aim of a ...
Breaking Biology Technology: